First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial

Both human immunodeficiency virus–infected and human immunodeficiency virus–exposed, uninfected children living in Brazil, Argentina, and Mexico have similar rates of low concentrations of retinol, β-carotene, and vitamin E